| Richard Gumer |
Richard Gumer is the founder of Life Sciences Alternative Funding LLC, which was founded in 2013. He held the position of Chief Executive Officer from 2013 to 2018. Mr. Gumer currently holds positions as Director at EchoNous, Inc., Chief Financial Officer, Secretary & Director at KL Acquisition Corp., and Partner at Kennedy Lewis Investment Management LLC. Mr. Gumer was also a Senior Advisor at Healthcare Royalty Management LLC in 2012. Mr. Gumer received his undergraduate degree from Brown University in 1979 and his Masters of Business Administration from the University of California, Berkeley in 1984. |
| Douglas T. Logigian |
Mr. Douglas T. Logigian is a Co-Managing Partner & President at Kennedy Lewis Investment Management LLC and a Chairman & Chief Executive Officer at KL Acquisition Corp. Mr. Logigian was previously employed as a Senior Managing Director by GSO Capital Partners LP, an Associate by Citibank (Nevada), NA, and a Research Analyst by DiMaio Ahmad Capital LLC. He also served on the board at Town Sports International Holdings, Inc. and Seneca Mortgage Management LLC. He received his undergraduate degree from Harvard University. |
| David Kho |
David Kho is currently the Director at CardioFocus, Inc. and the Managing Director at Kennedy Lewis Investment Management LLC. He is also the Chief Operating Officer & Director at KL Acquisition Corp. Previously, he worked as the Director at Samsara Vision, Inc. from 2016 to 2018, Director-Mergers & Acquisitions at Yaras Group in 2018, Vice President at Bridge Bank, NA (San Jose, California) from 2018 to 2019, Performance Analyst at Hatteras Investment Partners LLC, Vice President at Square 1 Bank from 2008 to 2014, and Vice President at Life Sciences Alternative Funding LLC from 2014 to 2018. Mr. Kho obtained his undergraduate degree from The University of North Carolina at Chapel Hill in 2005. |
| Gregory David Casciaro |
Gregory David Casciaro is currently the Chief Executive Officer at Foldax, Inc., an Independent Director at Colospan Ltd., and a Director at Yor Labs, Inc. He is also a Director at Tulavi Therapeutics, Inc., Cytokind, Inc., and an Independent Director at KL Acquisition Corp. In the past, he served as President & Chief Executive Officer at General Surgical Innovations, Inc., President, Chief Executive Officer & Director at Cardiac Dimensions, Inc., Access Closure, Inc., Orquest, Inc., and Xtent, Inc. He was also a Director at Kerberos Proximal Solutions, Inc., Trireme Medical LLC, Apama Medical, Inc., AngioDynamics, Inc., and Dextera Surgical, Inc. Additionally, he served as an Independent Non-Executive Director at QT Vascular Ltd. He started his career as a Manager-Area Sales at North American Instrument Corp. and later became Vice President-Sales at Devices for Vascular Intervention, Inc. Casciaro received his undergraduate degree from Marquette University in 1982. |
| Andrew A. Krakauer |
Andrew A. Krakauer is an Independent Director at Teleflex, Inc. and KL Acquisition Corp. He was the Chief Executive Officer & Director at Cantel Medical LLC from 2014 to 2016. He was also the President & Chief Executive Officer at Medivators, Inc. and President-Ohmeda Medical Division at Instrumentarium Oyj and GE Healthcare Ltd. (United Kingdom) from 1998 to 2004. Mr. Krakauer holds an MBA degree from The University of Chicago and an undergraduate degree from State University of New York at Binghamton. |
| James L. Bierman |
James L. Bierman is an Independent Director at Tenet Healthcare Corp., MiMedx Group, Inc., and KL Acquisition Corp. He was the President, Chief Executive Officer & Director at Owens & Minor, Inc. from 2014 to 2015. He was also the Chief Financial Officer, Director & Executive VP at Quintiles Transnational Corp. from 2001 to 2004. He served as a Director at Team Health, Inc. and Pharma Services Holding, Inc. He was the Lead Independent Director at Team Health Holdings, Inc. from 2016 to 2017. He was a Partner at Arthur Andersen LLP from 1988 to 1998. He received his undergraduate degree from Dickinson College and his MBA from Johnson Graduate School of Management. Currently, he holds positions at Tenet Healthcare Corp., MiMedx Group, Inc., and KL Acquisition Corp. |
| Rafael Antonio Torres |
Rafael Antonio Torres is currently a Managing Director at Altaris Capital Partners LLC, a Director at Latino Corporate Directors Association, an Independent Director at KL Acquisition Corp., and a Board Member at HealthTronics, Inc. In the past, he was a Director at LipoScience, Inc., CardioDx, Inc., NaviNet, Inc., Insightec, Inc., and Head of Healthcare at GE Ventures LLC. He was also a Senior VP-Strategy & Corporate Development at Varian Medical Systems, Inc. Mr. Torres holds an undergraduate degree from Universidad del PacÃfico and an MBA from Harvard Business School. |
